Navellier & Associates’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,143
Closed -$179K 290
2020
Q3
$179K Sell
10,143
-134,431
-93% -$2.5M 0.04% 218
2020
Q2
$2.72M Buy
144,574
+857
+0.6% +$15.2K 0.65% 52
2020
Q1
$2.48M Sell
143,717
-5,892
-4% -$123K 0.58% 44
2019
Q4
$3.16M Buy
149,609
+2,993
+2% +$60.6K 0.51% 54
2019
Q3
$2.87M Buy
146,616
+6,238
+4% +$115K 0.47% 55
2019
Q2
$2.45M Sell
140,378
-2,423
-2% -$43.6K 0.38% 73
2019
Q1
$2.64M Sell
142,801
-979
-0.7% -$17.5K 0.41% 66
2018
Q4
$2.31M Buy
143,780
+3,055
+2% +$48.3K 0.39% 59
2018
Q3
$2.1M Buy
+140,725
New +$2.05M 0.27% 104

Other funds holding MPT

Navellier & Associates's MPT Position: Q4 2020 in Review

Navellier & Associates sold out of Medical Properties Trust (MPT) in Q4 2020, closing a stake of 10,143 shares — an estimated $179K sold.

Navellier & Associates first reported a position in MPT in Q3 2018 and held it in 9 quarters. The position peaked at $3.16M in Q4 2019. 537 funds tracked by Wall St. Rank hold MPT as of Q4 2020.

  • Navellier & Associates reported no remaining Medical Properties Trust position as of Q4 2020 after selling out during the quarter.
  • Navellier & Associates sold 10,143 Medical Properties Trust shares in Q4 2020, an estimated $179K.
  • Navellier & Associates first reported a position in Medical Properties Trust in Q3 2018 and held it in 9 quarters.
  • Navellier & Associates's Medical Properties Trust position peaked at $3.16M in Q4 2019.
  • 537 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2020.

Based on Navellier & Associates's 13F filing for Q4 2020, filed 5 Feb 2021.